
    
      Participants in this multicenter, double-blind study are randomized to receive
      trimethoprim-sulfamethoxazole or placebo for 10 days postoperatively. Short- and
      intermediate-term results will be published after participants complete 6 months and 5 years
      of follow-up, respectively.
    
  